Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence

This study has been completed.
Sponsor:
Collaborator:
Innovacell Biotechnologie AG
Information provided by:
University Medical Centre Ljubljana
ClinicalTrials.gov Identifier:
NCT01355133
First received: May 12, 2011
Last updated: May 16, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):